Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Jun;91(6):2586–2595. doi: 10.1172/JCI116497

The serology of chronic hepatitis B infection revisited.

T Maruyama 1, A McLachlan 1, S Iino 1, K Koike 1, K Kurokawa 1, D R Milich 1
PMCID: PMC443322  PMID: 8514870

Abstract

The serology of chronic hepatitis B infection has been established through the use of commercial immunoassays to measure the structural antigens of the hepatitis B virus and their respective antibodies in serum. However, the commercial assays have not been designed to detect serum antibodies in the presence of an excess of circulating antigens. A series of serum samples from 200 HBeAg-positive, chronically infected hepatitis B patients with varying degrees of liver disease were analyzed using novel immunoassays designed to detect antibodies in the presence of circulating viral antigens. All patients, regardless of their liver disease, were seronegative for antibodies specific for the envelope antigens or the secreted nucleoprotein antigen (HBeAg) when the commercial assays were used. In contrast, virtually all chronically infected patients with liver disease and approximately 50% of patients without liver disease demonstrated anti-HBe and anti-envelope antibodies when sera were tested in the more sensitive immunoassays. Furthermore, asymptomatic patients could be serologically distinguished from symptomatic patients based on antibody fine specificity, titer, and IgG subclass. This study revealed that the majority of chronically infected hepatitis B patients produce a variety of antibodies for many years, and are not immunologically unresponsive, as suggested by the current assays.

Full text

PDF

Images in this article

2588Image
on p.2588

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anh-Tuan N., Novák E. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with hepatitis B and asymptomatic HBsAg carriers. Clin Exp Immunol. 1981 Feb;43(2):246–253. [PMC free article] [PubMed] [Google Scholar]
  2. Arakawa K., Tsuda F., Takahashi K., Ise I., Naito S., Kosugi E., Miyakawa Y., Mayumi M. Maternofetal transmission of IgG-bound hepatitis B e antigen. Pediatr Res. 1982 Mar;16(3):247–250. doi: 10.1203/00006450-198203000-00017. [DOI] [PubMed] [Google Scholar]
  3. Beasley R. P., Hwang L. Y., Lin C. C., Chien C. S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981 Nov 21;2(8256):1129–1133. doi: 10.1016/s0140-6736(81)90585-7. [DOI] [PubMed] [Google Scholar]
  4. Beck O. E. Distribution of virus antibody activity among human IgG subclasses. Clin Exp Immunol. 1981 Mar;43(3):626–632. [PMC free article] [PubMed] [Google Scholar]
  5. Brown S. E., Steward M. W., Viola L., Howard C. R., Murray-Lyon I. M. Chronic liver disease: the detection and characterization of circulating immune complexes. Immunology. 1983 Aug;49(4):673–683. [PMC free article] [PubMed] [Google Scholar]
  6. Burstein H. J., Shea C. M., Abbas A. K. Aqueous antigens induce in vivo tolerance selectively in IL-2- and IFN-gamma-producing (Th1) cells. J Immunol. 1992 Jun 15;148(12):3687–3691. [PubMed] [Google Scholar]
  7. Carman W. F., Jacyna M. R., Hadziyannis S., Karayiannis P., McGarvey M. J., Makris A., Thomas H. C. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet. 1989 Sep 9;2(8663):588–591. doi: 10.1016/s0140-6736(89)90713-7. [DOI] [PubMed] [Google Scholar]
  8. De Wit D., Van Mechelen M., Ryelandt M., Figueiredo A. C., Abramowicz D., Goldman M., Bazin H., Urbain J., Leo O. The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes. J Exp Med. 1992 Jan 1;175(1):9–14. doi: 10.1084/jem.175.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Delos S., Villar M. T., Hu P., Peterson D. L. Cloning, expression, isolation and characterization of the pre-S domains of hepatitis B surface antigen, devoid of the S protein. Biochem J. 1991 Jun 1;276(Pt 2):411–416. doi: 10.1042/bj2760411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ferrari C., Mondelli M. U., Penna A., Fiaccadori F., Chisari F. V. Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines. J Immunol. 1987 Jul 15;139(2):539–544. [PubMed] [Google Scholar]
  11. Ferrari C., Penna A., Giuberti T., Tong M. J., Ribera E., Fiaccadori F., Chisari F. V. Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol. 1987 Sep 15;139(6):2050–2058. [PubMed] [Google Scholar]
  12. Ferrari C., Penna A., Sansoni P., Giuberti T., Neri T. M., Chisari F. V., Fiaccadori F. Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B. Clin Exp Immunol. 1986 Dec;66(3):497–506. [PMC free article] [PubMed] [Google Scholar]
  13. Hoofnagle J. H., Dusheiko G. M., Seeff L. B., Jones E. A., Waggoner J. G., Bales Z. B. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med. 1981 Jun;94(6):744–748. doi: 10.7326/0003-4819-94-6-744. [DOI] [PubMed] [Google Scholar]
  14. Imai M., Nomura M., Gotanda T., Sano T., Tachibana K., Miyamoto H., Takahashi K., Toyama S., Miyakawa Y., Mayumi M. Demonstration of two distinct antigenic determinants on hepatitis B e antigen by monoclonal antibodies. J Immunol. 1982 Jan;128(1):69–72. [PubMed] [Google Scholar]
  15. Inoue M., Kakumu S., Yoshioka K., Tsutsumi Y., Wakita T., Arao M. Hepatitis B core antigen-specific IFN-gamma production of peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection. J Immunol. 1989 Jun 1;142(11):4006–4011. [PubMed] [Google Scholar]
  16. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  17. Langley K. E., Egan K. M., Barendt J. M., Parker C. G., Bitter G. A. Characterization of purified hepatitis B surface antigen containing pre-S(2) epitopes expressed in Saccharomyces cerevisiae. Gene. 1988 Jul 30;67(2):229–245. doi: 10.1016/0378-1119(88)90400-3. [DOI] [PubMed] [Google Scholar]
  18. Lieberman H. M., LaBrecque D. R., Kew M. C., Hadziyannis S. J., Shafritz D. A. Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers. Hepatology. 1983 May-Jun;3(3):285–291. doi: 10.1002/hep.1840030302. [DOI] [PubMed] [Google Scholar]
  19. Machida A., Kishimoto S., Ohnuma H., Baba K., Ito Y., Miyamoto H., Funatsu G., Oda K., Usuda S., Togami S. A polypeptide containing 55 amino acid residues coded by the pre-S region of hepatitis B virus deoxyribonucleic acid bears the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology. 1984 May;86(5 Pt 1):910–918. [PubMed] [Google Scholar]
  20. Maruyama T., Thornton G. B., Iino S., Kurokawa K., Milich D. R. Use of anti-peptide antibodies for the design of antigen-specific immune complex assays. J Immunol Methods. 1992 Oct 19;155(1):65–75. doi: 10.1016/0022-1759(92)90272-u. [DOI] [PubMed] [Google Scholar]
  21. Milich D. R. Immune response to hepatitis B virus proteins: relevance of the murine model. Semin Liver Dis. 1991 May;11(2):93–112. doi: 10.1055/s-2008-1040428. [DOI] [PubMed] [Google Scholar]
  22. Milich D. R., Jones J. E., Hughes J. L., Price J., Raney A. K., McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A. 1990 Sep;87(17):6599–6603. doi: 10.1073/pnas.87.17.6599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Milich D. R., McLachlan A., Raney A. K., Houghten R., Thornton G. B., Maruyama T., Hughes J. L., Jones J. E. Autoantibody production in hepatitis B e antigen transgenic mice elicited with a self T-cell peptide and inhibited with nonself peptides. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4348–4352. doi: 10.1073/pnas.88.10.4348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Milich D. R., McLachlan A., Stahl S., Wingfield P., Thornton G. B., Hughes J. L., Jones J. E. Comparative immunogenicity of hepatitis B virus core and E antigens. J Immunol. 1988 Nov 15;141(10):3617–3624. [PubMed] [Google Scholar]
  25. Milich D. R., McLachlan A. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science. 1986 Dec 12;234(4782):1398–1401. doi: 10.1126/science.3491425. [DOI] [PubMed] [Google Scholar]
  26. Milich D. R., McLachlan A., Thornton G. B., Hughes J. L. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature. 1987 Oct 8;329(6139):547–549. doi: 10.1038/329547a0. [DOI] [PubMed] [Google Scholar]
  27. Mills F. C., Brooker J. S., Camerini-Otero R. D. Sequences of human immunoglobulin switch regions: implications for recombination and transcription. Nucleic Acids Res. 1990 Dec 25;18(24):7305–7316. doi: 10.1093/nar/18.24.7305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Okamoto H., Yotsumoto S., Akahane Y., Yamanaka T., Miyazaki Y., Sugai Y., Tsuda F., Tanaka T., Miyakawa Y., Mayumi M. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol. 1990 Mar;64(3):1298–1303. doi: 10.1128/jvi.64.3.1298-1303.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pernice W., Sodomann C. P., Lüben G., Seiler F. R., Sedlacek H. H. Antigen-specific detection of HBsAG-containing immune complexes in the course of hepatitis B virus infection. Clin Exp Immunol. 1979 Aug;37(2):376–380. [PMC free article] [PubMed] [Google Scholar]
  30. Peters M., Davis G. L., Dooley J. S., Hoofnagle J. H. The interferon system in acute and chronic viral hepatitis. Prog Liver Dis. 1986;8:453–467. [PubMed] [Google Scholar]
  31. Rath S., Devey M. E. IgG subclass composition of antibodies to HBsAg in circulating immune complexes from patients with hepatitis B virus infections. Clin Exp Immunol. 1988 Apr;72(1):164–167. [PMC free article] [PubMed] [Google Scholar]
  32. Realdi G., Alberti A., Rugge M., Bortolotti F., Rigoli A. M., Tremolada F., Ruol A. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology. 1980 Aug;79(2):195–199. [PubMed] [Google Scholar]
  33. Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol Today. 1991 Aug;12(8):256–257. doi: 10.1016/0167-5699(91)90120-I. [DOI] [PubMed] [Google Scholar]
  34. Skvaril F., Joller-Jemelka H. IgG subclasses of anti-HBs antibodies in vaccinated and nonvaccinated individuals and in anti-HBs immunoglobulin preparations. Int Arch Allergy Appl Immunol. 1984;73(4):330–337. doi: 10.1159/000233493. [DOI] [PubMed] [Google Scholar]
  35. Snapper C. M., Paul W. E. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science. 1987 May 22;236(4804):944–947. doi: 10.1126/science.3107127. [DOI] [PubMed] [Google Scholar]
  36. Stahl S., MacKay P., Magazin M., Bruce S. A., Murray K. Hepatitis B virus core antigen: synthesis in Escherichia coli and application in diagnosis. Proc Natl Acad Sci U S A. 1982 Mar;79(5):1606–1610. doi: 10.1073/pnas.79.5.1606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sällberg M., Norder H., Lindh G., Magnius L. O. IgG subclasses in circulating immune complexes with hepatitis B e antigen in chronic hepatitis B. Clin Exp Immunol. 1991 Apr;84(1):116–121. [PMC free article] [PubMed] [Google Scholar]
  38. Takahashi K., Kishimoto S., Ohori K., Yoshizawa H., Machida A., Ohnuma H., Tsuda F., Munekata E., Miyakawa Y., Mayumi M. Molecular heterogeneity of e antigen polypeptides in sera from carriers of hepatitis B virus. J Immunol. 1991 Nov 1;147(9):3156–3160. [PubMed] [Google Scholar]
  39. Takahashi K., Machida A., Funatsu G., Nomura M., Usuda S., Aoyagi S., Tachibana K., Miyamoto H., Imai M., Nakamura T. Immunochemical structure of hepatitis B e antigen in the serum. J Immunol. 1983 Jun;130(6):2903–2907. [PubMed] [Google Scholar]
  40. Terazawa S., Kojima M., Yamanaka T., Yotsumoto S., Okamoto H., Tsuda F., Miyakawa Y., Mayumi M. Hepatitis B virus mutants with precore-region defects in two babies with fulminant hepatitis and their mothers positive for antibody to hepatitis B e antigen. Pediatr Res. 1991 Jan;29(1):5–9. doi: 10.1203/00006450-199101000-00002. [DOI] [PubMed] [Google Scholar]
  41. Thomas H. C., De Villiers D., Potter B., Hodgson H., Jain S., Jewell D. P., Sherlock S. Immune complexes in acute and chronic liver disease. Clin Exp Immunol. 1978 Feb;31(2):150–157. [PMC free article] [PubMed] [Google Scholar]
  42. Tsai S. L., Chen P. J., Lai M. Y., Yang P. M., Sung J. L., Huang J. H., Hwang L. H., Chang T. H., Chen D. S. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. J Clin Invest. 1992 Jan;89(1):87–96. doi: 10.1172/JCI115590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Vento S., Hegarty J. E., Alberti A., O'Brien C. J., Alexander G. J., Eddleston A. L., Williams R. T lymphocyte sensitization to HBcAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease. Hepatology. 1985 Mar-Apr;5(2):192–197. doi: 10.1002/hep.1840050206. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES